L. Lind et al., INFLUENCES OF DIFFERENT ANTIHYPERTENSIVE TREATMENTS ON INDEXES OF SYSTEMIC MINERAL METABOLISM, American journal of hypertension, 7(4), 1994, pp. 302-307
A negative calcium balance has previously been described in human hype
rtension with low levels of plasma ionized calcium (Ca2+) and an incre
ased urinary excretion of calcium. The cause of this disturbance in mi
neral metabolism is not known, nor is it known if this derangement cou
ld be abolished if blood pressure is reduced by antihypertensive treat
ment. In the present investigation, the effects of antihypertensive mo
notherapy on serum and fasting urinary electrolytes were studied. For
3 to 6 months, 319 hypertensive patients entered 17 study groups, each
group using one of the following antihypertensive drugs: dilevalol, m
etoprolol, atenolol, pindolol, propranolol, hydrochlorothiazide, bendr
ofluomethiazide, furosemide, spironolactone, doxazocine, prazocine, di
ltiazem, verapamil, nifedipine, isradipine, captopril, or lisinopril.
Treatment with different beta-blockers, as well as diuretics, reduced
the fasting urinary calcium excretion (P < .001). However, while the b
eta-blockers increased the proportion of the ionized form of calcium i
n blood (Ca2+) (P < .001), Ca2+ was further decreased by diuretic trea
tment (P < .05). Angiotensin converting enzyme inhibitors caused no ma
jor changes in mineral metabolism while of the calcium antagonists stu
died only verapamil raised the levels of Ca2+ (P < .01). No significan
t relationship between the changes in mineral metabolism and the reduc
tion in blood pressure was observed in any of the treatment groups. Of
the antihypertensive drugs used in the present study, beta-blockers a
ppeared to reverse the basic abnormality with regard to calcium balanc
e, suggesting that the activity of the sympathetic nerve system is inv
olved in the disturbed calcium metabolism seen in hypertensive patient
s.